Two Sigma Ventures, LP Recursion Pharmaceuticals, Inc. Transaction History
Two Sigma Ventures, LP
- $9.61 Million
- Q3 2022
A detailed history of Two Sigma Ventures, LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Ventures, LP holds 903,400 shares of RXRX stock, worth $5.95 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
903,400
Previous 1,806,800
50.0%
Holding current value
$5.95 Million
Previous $14.7 Million
34.64%
% of portfolio
100.0%
Previous 88.76%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$224 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$213 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$164 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$114 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$96.7 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.19B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...